Cargando…

Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy

BACKGROUND: The prospective Neoadjuvant Breast Symphony Trial (NBRST) study found that MammaPrint/BluePrint functional molecular subtype is superior to conventional immunohistochemistry/fluorescence in situ hybridization subtyping for predicting pathologic complete response (pCR) to neoadjuvant chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baron, Paul, Beitsch, Peter, Boselli, Danielle, Symanowski, James, Pellicane, James V., Beatty, Jennifer, Richards, Paul, Mislowsky, Angela, Nash, Charles, Lee, Laura A., Murray, Mary, de Snoo, Femke A., Stork-Sloots, Lisette, Gittleman, Mark, Akbari, Stephanie, Whitworth, Pat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Breast Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819747/ https://www.ncbi.nlm.nih.gov/pubmed/26714960 http://dx.doi.org/10.1245/s10434-015-5030-1

Ejemplares similares

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
por: Whitworth, Pat, et al.
Publicado: (2014)

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping
por: Whitworth, Pat, et al.
Publicado: (2016)

Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
por: Whitworth, Pat, et al.
Publicado: (2022)

Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy
por: Whitworth, Pat W., et al.
Publicado: (2022)

Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups
por: Yao, Katharine, et al.
Publicado: (2015)

High concordance of 70‐gene recurrence risk signature and 80‐gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early‐stage breast cancer
por: Crozier, Jennifer A., et al.
Publicado: (2021)

The Clinical Utility of DCISionRT(®) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery
por: Shah, Chirag, et al.
Publicado: (2021)

Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
por: Minarikova, Lenka, et al.
Publicado: (2016)

Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis
por: Spick, Claudio, et al.
Publicado: (2017)

Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
por: Ragusi, Max A. A., et al.
Publicado: (2020)

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
por: Fangberget, A., et al.
Publicado: (2010)

Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations
por: Bedair, Reem, et al.
Publicado: (2016)

Comparison of the Diagnostic Performance of Response Evaluation Criteria in Solid Tumor 1.0 with Response Evaluation Criteria in Solid Tumor 1.1 on MRI in Advanced Breast Cancer Response Evaluation to Neoadjuvant Chemotherapy
por: Jeh, Su Kyung, et al.
Publicado: (2013)

Response to the article by Dietz et al. entitled “Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID‑19 pandemic. The COVID‑19 pandemic breast cancer consortium”
por: Beitsch, Peter, et al.
Publicado: (2020)

Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
por: Cao, Lifen, et al.
Publicado: (2021)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy
por: Murphy, Brenna M., et al.
Publicado: (2021)

Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature
por: Whitworth, Pat W., et al.
Publicado: (2022)

Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients
por: Koelbel, Vivian, et al.
Publicado: (2021)

A Novel Internal Negative Pressure Delivery System in Prepectoral Breast Reconstruction—Preliminary Experience
por: Paul, Robert
Publicado: (2022)

Reduction in Seroma and Other Complications with a Novel Internal Negative Pressure System in Breast Reconstruction
por: Paul, Robert
Publicado: (2023)

Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
por: Mamounas, Eleftherios, et al.
Publicado: (2016)

Recurrent Breast Animation after Conversion from Dual Plane to Prepectoral Breast Implant Placement
por: Pawaskar, Rishaan, et al.
Publicado: (2023)

A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe in Patients with Nonpalpable Breast Malignancies
por: Schnabel, Freya, et al.
Publicado: (2014)

Narrowing Racial Gaps in Breast Cancer: Factors Affecting Probability of Adjuvant Radiation Therapy
por: Snead, Felicia, et al.
Publicado: (2019)

Molecular hallmarks of breast multiparametric magnetic resonance imaging during neoadjuvant chemotherapy
por: Lin, Peng, et al.
Publicado: (2023)

Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic
por: Williams, Austin D., et al.
Publicado: (2021)

Immediate Breast Reconstruction After Neoadjuvant Chemotherapy: Factors Associated With Surgical Selection and Complications
por: Chi, Weiru, et al.
Publicado: (2023)

Use of Single-recipient Vessels for Cross-chest Abdominal Flap–based Breast Augmentation as an Outpatient
por: Deramo, Paul, et al.
Publicado: (2020)

The Modified M-plasty Approach to Mastectomy: Avoiding the Lateral Dog-ear
por: Meybodi, Farid, et al.
Publicado: (2022)

Magnetic Resonance Imaging Evaluation of Noninflammatory Breast Cancer with Skin Involvement After Neoadjuvant Chemotherapy
por: Chen, Jeon-Hor, et al.
Publicado: (2010)

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
por: Truin, W., et al.
Publicado: (2015)

Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
por: Müller, Hannah Deborah, et al.
Publicado: (2019)

Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
por: Vernaci, Grazia, et al.
Publicado: (2023)

Applying the Approximating Clamp during Breast Microsurgery: Is Upside Down the Right Way Up?
por: Oldbury, Jordan W., et al.
Publicado: (2021)

Neighborhood socioeconomic status and low‐value breast cancer care
por: Chen, J. C., et al.
Publicado: (2022)

Postsurgical Outcomes with Meshes for Two-stage Prosthetic Breast Reconstruction in 20,817 Patients
por: Wells, Michael W., et al.
Publicado: (2022)

Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer
por: Kim, Yunju, et al.
Publicado: (2018)

Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer
por: Yoen, Heera, et al.
Publicado: (2023)

Does three-dimensional functional infrared imaging improve breast cancer detection based on digital mammography in women with dense breasts?
por: Hellgren, Roxanna J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8l94jbl1na5pl5s23p06d8qv8p